Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-84.99	54.52	363.32
Graham Fair Price	138.13	15.16	6.36
PEG	-97.16	0.06	-2.25
Price/Book	-1.69	14.31	14.56
Price/Cash Flow	53548.91	61606.68	114.83
Prices/Earnings	-82.03	29.37	163.47
Price/Sales	-52.57	36.58	77.11
Price/FCF	53548.91	61606.68	114.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.23	1.00	0.99
Operating Margin	106.34	0.73	0.35
ROA	466.48	0.02	< 0.005
ROE	0.02	0.12	447.13
ROIC	0.02	0.09	440.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	-0.06	19.76
Dividends QOQ	< 0.005	0.13	1443392.80
EBIT QOQ	-0.59	3.36	472.02
EPS QOQ	-0.73	4.60	533.58
FCF QOQ	-0.15	-1.00	-553.26
Revenue QOQ	-0.46	1.11	144.33
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	325.82	161.84	-50.33
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.63	0.61	-2.79
Quick Ratio	3.25	1.41	-56.72
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.99	9.15	1.81
Cash	4.32	3.52	-18.51
Capex	-0.04	-0.02	43.44
Free Cash Flow	1.14	< 0.005	-99.81
Revenue	1.70	3.58	111.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.21	0.47	-61.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	30.27	4.53	-85.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating